Georoc International, Inc.

Unisheff Ventures Limited

Paul Heath

Salvatore Moricca

Martin William Alexander Stewart

Simon Wright

Ronald Carl Alan Pearson

Paul Orange

A canister for interim storage and subsequent consolidation of waste materials via hot pressing and comprising at least one ion exchange material. The canister is configured to house the ion exchange material after it is exchanged with a contaminating ion without releasing the contaminating ion and to consolidate waste materials via hot-isostatic pressing. A method comprising contacting a fluid waste with an ion exchange material.

Integrated ion-exchange disposal and treatment system

A method for treating a fluid waste, comprising adding one or more process additives to the fluid waste in an amount sufficient to change the wasteform chemistry is disclosed. The addition step may be chosen from adding a dispersant or a deflocculant an additive to decrease the reactive metal components, to bind fission products and decrease volatilization of toxic or radioactive elements or species during thermal treatment, or to target and react with the fine particle size component of the waste to decrease dusting and immobilize components in a durable phase. After mixing the fluid waste with the described additives the waste is eventually hot-isostatic pressing, to form a durable and stable waste form.

Process for treating fluid wastes

A group of oligonucleotides for the identification of sequences in a sample comprising human histamine H receptor DNA, cDNA or RNA originating from a tissue sample or body fluid is employed in the diagnosis and/or treatment of human neurological and psychiatric disorders, particularly schizophrenia, and diseases of other systems or organs of the human body. The oligonucleotides, suitable for use as primers for the amplification of DNA corresponding to a region of a human histamine H receptor, have nucleotide sequences selected from: 5&prime;ACACCAGCCTGGATGTGA 3&prime;(as listed in SEQ ID NO:12), 5&prime;TCACATCCAGGCTGGTCT 3&prime; (as listed in SEQ ID NO:13), 5&prime; CAATCATACCACCTCTAA 3&prime; (as listed in SEQ ID NO:14), 5&prime; ACACAAACGCGGTGAAGT 3&prime;(as listed in SEQ ID NO:15). Also described is a diagnostic kit comprising one or more of the above mentioned oligonucleotides.

Growing community of inventors

Sheffield, United Kingdom

Paul Heath